Differences among immunosuppressive agents.
Immunosuppressive agents have diverse (although often multiple) sites of action in the cell sequences that are involved in immune responses. New routes to selectivity are apparent at both the cellular and the biochemical level. Meanwhile, clinical work is finding new uses and more selective employment of the currently available agents.
D000243:Adenosine Deaminase / Q000172:deficiency; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D011683:Purine-Nucleoside Phosphorylase / Q000172:deficiency; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000188:drug therapy; D011817:Rabbits; D013950:Thymus Gland / Q000187:drug effects
D007166:Immunosuppressive Agents; D011683:Purine-Nucleoside Phosphorylase; D000243:Adenosine Deaminase